1. Eye, hepatobiliary, and renal disorders of erlotinib in patients with non-small-cell lung cancer: A meta-analysis
   Hye Duck Choi et al, 2020, PLOS ONE CrossRef
2. Pneumonitis in advanced non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitor: Meta-analysis of 153 cohorts with 15,713 patients
   Chong Hyun Suh et al, 2018, Lung Cancer CrossRef
3. Mallory‐Weise syndrome in a patient treated with EGFR‐TKI
   Shinichiro Okauchi et al, 2017, Journal of General and Family Medicine CrossRef